Mutagenicity to Salmonella of the mono methylamino and N-cyanoethyl analogues of 4-dimethylaminoazobenzene (DAB) and 6-dimethylaminophenylazobenzthiazole (6BT)
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Mutation Research
- Vol. 128 (1), 11-16
- https://doi.org/10.1016/0027-5107(84)90041-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- 6-p-Dimethylaminophenylazobenzothiazole: A potent hepatocarcinogen in the ratCancer Letters, 1983
- The unique role of rodents in the detection of possible human carcinogens and mutagensMutation Research/Reviews in Genetic Toxicology, 1983
- Initiation/promotion versus complete carcinogenicity in the rodent liverEnvironmental Health Perspectives, 1983
- The possible role of azoreduction in the bacterial mutagenicity of 4-dimethylaminoazobenzene (DAB) and 2 of its analogues (6BT and 5I)Mutation Research/Genetic Toxicology, 1983
- Cyclic amines as less mutagenic replacements for dimethyl amino (-NMe2) substituents on aromatic organic compounds: Implications for carcinogenicity and toxicityCancer Letters, 1983
- Comparisons between carcinogenic potency and mutagenic potency to Salmonell in a series of derivatives of 4-dimethylaminozobenzene (DAB)Mutation Research, 1982
- The effects of pre-incubation period and norharman on the mutagenic potency of 4-dimethylaminoazobenzene and 3′-methyl-4-dimethylaminoazobenzene in S. typhimuriumCarcinogenesis: Integrative Cancer Research, 1981
- Mutagenic studies with acrylonitrileMutation Research, 1977
- Carcinogenic activity of analogs of p-dimethylaminoazobenzene. VI. Activity of the benzimidazole and benzthiazole analogsJournal of Medicinal Chemistry, 1968
- The Carcinogenic Aminoazo DyesAdvances in Cancer Research, 1953